The combination heart failure drug sacubitril/valsartan is well-covered under Medicare Part D plans, according to a recent analysis, but patient access to the medication remains limited by steep out-of-pocket costs than can exceed $1,600 annually.

Developments within and beyond healthcare have created a need for workers with upgraded skillsets. Upskilling might help fulfill this need.

Customized dashboards are helping health systems, hospitals and practices realize improvements in quality and cost of care.

The opportunities to bring in new money for non-face-to-face services are encouraging, but the requirements present obstacles.

Spontaneous coronary artery dissection is emerging from the shadows as an important cause of myocardial infarction in younger women. That visibility is leading to fundamental changes in how the condition is diagnosed and treated.

Sanjaya Gupta, MD, MBA, details how his practice is leverage wearables as a patient engagement tool.

The Affordable Care Act is back in court this week after a Texas judge ruled the law unconstitutional in late 2018, prompting the American Heart Association and other major societies to issue a joint statement supporting the ACA and its protections for patients with pre-existing conditions.

A miniscule fiber-optic sensor could outperform more traditional methods for monitoring blood flow during prolonged and intensive surgical CV procedures, even in the smallest and youngest heart patients, researchers at Flinders University in Australia report.

Employees who work in what they consider a closed-off and untrusting environment are more likely to develop CVD risk factors like elevated blood pressure, high cholesterol and diabetes than those who feel their bosses support them, according to a study published in the International Journal of Environmental Research and Public Health.

Sometimes a move in the right direction starts with a good hard look in the rearview mirror, then breaking it off to start anew with greater wisdom.

A recent study of autopsy data in Finland suggests nearly half of individuals who experience sudden cardiac death without a prior diagnosis of CAD actually had a history of silent MI—but that history wasn’t detected until after their deaths.

Cardiologists discuss the questions and concerns swirling around the thriving wearables market as patients strap on a variety of smart devices and expect their physicians to catch up.